Robust derivation of epicardium and its differentiated smooth muscle cell progeny from human pluripotent stem cells.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed.

1. Current Trends in Duchenne Muscular Dystrophy Research and Therapy: 3D Cardiac Modelling.Journal of cachexia, sarcopenia and muscle · 2026
   Review
2. Effect of iPS cell culture medium on the differentiation potential of induced cardiac tissues.Scientific reports · 2025
   Article
3. Exploring the Function of Epicardial Cells Beyond the Surface.Circulation research · 2024
   Review
4. Epicardially secreted fibronectin drives cardiomyocyte maturation in 3D-engineered heart tissues.Stem cell reports · 2023
   Article
5. Recapitulating porcine cardiac developmentFrontiers in cell and developmental biology · 2023
   Article
6. Human iPS-derived pre-epicardial cells direct cardiomyocyte aggregation expansion and organization in vitro.Nature communications · 2021
   Article
7. The extracellular matrix protein agrin is essential for epicardial epithelial-to-mesenchymal transition during heart development.Development (Cambridge, England) · 2021
   Article
8. Cardiac cell type-specific responses to injury and contributions to heart regeneration.Cell regeneration (London, England) · 2021
   Review
9. Pluripotent Stem Cells for Cell Therapy.Methods in molecular biology (Clifton, N.J.) · 2021
   Article
10. Notch and Bmp signaling pathways act coordinately during the formation of the proepicardium.Developmental dynamics : an official publication of the American Association of Anatomists · 2020
    Article
11. Modeling Cardiovascular Diseases with hiPSC-Derived Cardiomyocytes in 2D and 3D Cultures.International journal of molecular sciences · 2020
    Review
12. Stem cell therapy of myocardial infarction: a promising opportunity in bioengineering.Advanced therapeutics · 2020
    Article
13. Generation of Quiescent Cardiac Fibroblasts From Human Induced Pluripotent Stem Cells for In Vitro Modeling of Cardiac Fibrosis.Circulation research · 2019
    Article
14. A Novel Human Pluripotent Stem Cell-Derived Neural Crest Model of Treacher Collins Syndrome Shows Defects in Cell Death and Migration.Stem cells and development · 2019
    Article
15. Engineered Microenvironment for Manufacturing Human Pluripotent Stem Cell-Derived Vascular Smooth Muscle Cells.Stem cell reports · 2019
    Article
16. CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy.European heart journal · 2018
    Article
17. Wnt inhibition promotes vascular specification of embryonic cardiac progenitors.Development (Cambridge, England) · 2018
    Article
18. Engineering Scalable Manufacturing of High-Quality Stem Cell-Derived Cardiomyocytes for Cardiac Tissue Repair.Frontiers in medicine · 2018
    Review

Corrections and comments

• Erratum for
  Robust derivation of epicardium and its differentiated smooth muscle cell progeny from human pluripotent stem cells.2015

Authors and funding

8 authors.

Funding

Abstract

PubMed holds no abstract for this paper.